Drug stores are favored over grocery stores, mass retailers and online for pharmacy and medical needs, per Acosta Group's Drug Store Channel Shopper Insights study.
The acquisition provides GSK access to Camlipixant, a P2X3 antagonist currently in phase III development for the first-line treatment of adult patients with RCC.